tirzepatide podcast 1st longer term study (3 years) - Docs Who Lift Tirzepatide updates from EASD -

Ask A Pharmacist Online About GLP-1 Medications Want additional live support with your injectable GLP-1 agonist medication questions

People taking Victoza may lose about 2% of their body weight in a year, while those on Mounjaro lose 6% to 8% in a shorter time

The research vs pharmaceutical peptides comparison explains these differences in detail

The clinical consensus is that if semaglutide alone isn't working, dose escalation or genetic testing to find alternative compounds (such as tirzepatide) is safer than adding a second drug class

For example, someone who dislikes injections might skip doses, reducing the medications effectiveness

And it is pretty rewarding to get those folks to transition and see the value in it